Erik Greb joined the staff of Neurology Reviews in January 2012. Since then, he has attended scientific conferences, conducted video interviews, and written about clinical research in multiple sclerosis, epilepsy, Parkinson's disease, Alzheimer's disease, stroke, and other neurologic disorders. In addition to news articles, Erik has written investigative stories about multiple sclerosis, headache, and epilepsy. He previously wrote about pharmaceutical manufacturing, drug formulation and delivery, quality assurance, and regulation for Pharmaceutical Technology.
News
Mutant huntingtin and neurofilament light are potential biomarkers in Huntington’s disease
- Author:
- Erik Greb
Publish date: June 11, 2019
News
Treatment for hepatitis C reduces risk of Parkinson’s disease
- Author:
- Erik Greb
Publish date: June 6, 2019
News

Stewart Tepper: Emgality approval ‘very exciting’
- Author:
- Erik Greb
Publish date: June 5, 2019
News
Switching from interferon beta-1a to alemtuzumab improves MS outcomes
- Author:
- Erik Greb
Publish date: June 3, 2019
News
High-efficacy DMTs may reduce depressive symptoms in MS
- Author:
- Erik Greb
Publish date: May 30, 2019
News
Patients with MS who consider using marijuana are more likely to engage in risky behaviors
- Author:
- Erik Greb
Publish date: May 30, 2019
News
Fingolimod reduces MS disease activity, compared with glatiramer acetate
- Author:
- Erik Greb
Publish date: May 30, 2019
News
Adherence to oral treatments for MS is poor
- Author:
- Erik Greb
Publish date: May 30, 2019
News
Extended-release arbaclofen reduces MS-related spasticity
- Author:
- Erik Greb
Publish date: May 30, 2019
News
Alemtuzumab increases the likelihood of disability improvement in MS
- Author:
- Erik Greb
Publish date: May 28, 2019
News
MS significantly affects employment and home activities
- Author:
- Erik Greb
Publish date: May 28, 2019
News
Anxiety and fatigue impair processing speed in MS
- Author:
- Erik Greb
Publish date: May 28, 2019
News
Age may influence choice of behavioral therapy to improve sleep in MS
- Author:
- Erik Greb
Publish date: May 28, 2019
News
Periodic limb movements during sleep are common in patients with MS and fatigue
- Author:
- Erik Greb
Publish date: May 28, 2019
News
Alemtuzumab provides greater reductions in serum NfL than interferon beta-1a
- Author:
- Erik Greb
Publish date: May 28, 2019